期刊文献+

Screening and comprehensive analysis of key genes in liver hepatocellular carcinoma based on bioinformatics

下载PDF
导出
摘要 Objective:To search and analyze the related genes of liver hepatocellular carcinoma(LIHC)by using bioinformatics technology.Methods:Gene expression omnibus(GEO)was used to retrieve the entry of"Liver hepatocellular carcinoma",and GSE109903 chip data was downloaded.The differentially expressed genes in the control group and liver hepatocellular carcinoma group were screened by bioinformatics analysis.GO enrichment analysis,KEGG pathway analysis,differential gene expression analysis and visualization processing were performed for the differentially expressed genes;Protein interaction network analysis and visualization processing were used to screen core genes EEF1A1 and HK2 with strong correlation with liver hepatocellular carcinoma.GEPIA,Kaplan-Meier plotter,GeneMANIA and Timer 2.0 databases were used to analyze the differential expression,prognostic value and immune cell infiltration of key genes in LIHC.Results:A total of 1059 differentially expressed genes were screened,including 637 up-regulated genes and 872 downregulated genes.Functional analysis showed that differentially expressed genes were mainly involved in the process of positive transcription regulation,nucleosome function,chromatin function and RNA binding.Pathway analysis showed that differentially expressed genes were involved in systemic lupus erythematosus,alcoholism and RNA polymerase I promoter opening pathway.The analysis of differential gene expression showed that the drugs with similar gene characteristics were mainly CDC inhibitors,prostaglandins,serotonin receptor antagonists,BAF transcriptional repression inhibitors,tyrosine phosphatase inhibitors,etc;Protein interaction network analysis showed that the main genes associated with LIHC were EEF1A1,HK2,FAM38A and LAMB3;EEF1A1 and HK2 genes were further analyzed by GEPIA.The results showed that the expression of EEF1A1 and HK2 mRNA in LIHC tissues was higher than that in normal tissues,and was significantly correlated with the pathological stage,overall survival rate and disease-free survival rate of LIHC patients.EEF1A1 and HK2 may be potential prognostic biomarkers for LIHC patients.In addition,the functions of EEF1A1 and HK2 were mainly related to translation factor activity,molecular chaperone mediated autophagy and carbohydrate catabolism,and purine nucleoside diphosphate metabolism,respectively.Immunocyte infiltration showed that the expression of EEF1A1 and HK2 was significantly correlated with the infiltration of a variety of immune cells,including six types of immune cells:CD4+T cells,macrophages,neutrophils,B cells,CD8+T cells and dendritic cells.Conclusion:By screening differentially expressed genes,we can identify the key genes in the development of liver hepatocellular carcinoma,and screen potential prognostic biomarkers for the survival of patients with liver hepatocellular carcinoma.At the same time,this study provides new ideas and programs for clinical treatment of liver hepatocellular carcinoma.
出处 《Journal of Hainan Medical University》 2022年第21期33-42,共10页 海南医学院学报(英文版)
基金 supported by National Natural Science Foundation of China(No.81603418)。
  • 相关文献

参考文献6

二级参考文献78

  • 1陈孝平.肝切除治疗巨大肝癌的体会[J].肝胆外科杂志,1994,2(4):193-197. 被引量:22
  • 2蔡秀军,虞洪,郑雪咏,梁霄,王一帆,林立忠,黄迪宇,陈继达,杨进,沈波,戴益,杨瑾,彭淑牖.腹腔镜右半肝切除一例[J].中华医学杂志,2005,85(13):869-869. 被引量:35
  • 3孙成荣,唐建武,孙明忠,刘淑清,张宏颖,王波,宋波,张亚楠,张竹清,赵志英.采用定量蛋白质组学技术筛选小鼠肝癌淋巴道转移相关蛋白[J].生物化学与生物物理进展,2007,34(8):856-864. 被引量:21
  • 4Zimmerman MA, Ghobrial RM, Tong MJ, Hiatt JR, Cameron AM, Hong J, Busuttil RW. Recurrence of hepatocellular carcinoma following liver transplan- tation: a review of preoperative and postoperative prognostic indicators. Arch Surg 2008; 14:3: 182-188; discussion 188 [PMID: 18283144 DOI: 10.1001/arch- surg.2007.39143 / 2 /1821.
  • 5Chok KS, Chan SC, Cheung TT, Chan AC, Fan ST, Lo CM. Late recurrence of hepatocellular carcinoma after liver transplantation. World J Surg 2011; 35: 2058-2062 [PMID: 21597889 DOI: lO.1007/sOO268- 011-1146-z].
  • 6Mergental H, Porte RJ. Liver transplantation for unresectable hepatocellular carcinoma in pa- tients without liver cirrhosis. Transpl Int 2010; 23:662-667 [PMID: 20345561 DOI: 10.1111/ j.1432-2277.2010.01076.xTRI1076].
  • 7Crippin JS. Treatment of hepatocellular carcinoma after transplantation and human rights. Hepatology 2007; 45:263-265 [PMID: 17256762 DOh 10.1002/ hep.21545].
  • 8Merli M, Giusto M, Gentili F, Novelli G, Ferretti G, Riggio O, Corradini SG, Siciliano M, Farco- meni A, Attili AF, Berloco P, Rossi M. Nutritional status: its influence on the outcome of patients undergoing liver transplantation. Liver Int 2010; 30:208-214 [PMID: 19840246 DOI: 10.1111/ j.1478-3231.2009.02135.xLIV2135].
  • 9Bates MJ, Farkas E, Taylor D, McFadden PM. Pul- monary resection of metastatic hepatoce21ular car- cinoma after liver transplantation. Ann Thorac Surg 2008; 85:412-415 [PMID: 18222234 DOI: 10.1016/ j.athoracsur.2007.10.065S0003-4975(07)02195-9].
  • 10Di Sandro S, Giacomoni A, Slim A, Lauterio A, Mangoni I, Mihaylov P, Pirotta V, Aseni P, De Carlis L. Living donor liver transplantation for he- patocellular carcinoma: the impact of neo-adjuvant treatments on the long term results. H@atogastro- enterology 2012; 59:505-510 [PMID: 22353516 DOI: 10.5754/hge11225].

共引文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部